Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt No Debt
AVMXY's Cash to Debt is ranked higher than
93% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. AVMXY: No Debt )
Ranked among companies with meaningful Cash to Debt only.
AVMXY' s Cash to Debt Range Over the Past 10 Years
Min: 16.69  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.82
AVMXY's Equity to Asset is ranked higher than
81% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. AVMXY: 0.82 )
Ranked among companies with meaningful Equity to Asset only.
AVMXY' s Equity to Asset Range Over the Past 10 Years
Min: 0.51  Med: 0.91 Max: 0.99
Current: 0.82
0.51
0.99
Interest Coverage No Debt
AVMXY's Interest Coverage is ranked higher than
92% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 53.78 vs. AVMXY: No Debt )
Ranked among companies with meaningful Interest Coverage only.
AVMXY' s Interest Coverage Range Over the Past 10 Years
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 4
Z-Score: 5.36
WACC vs ROIC
2.37%
-1315.33%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -632.09
AVMXY's Operating margin (%) is ranked lower than
89% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.64 vs. AVMXY: -632.09 )
Ranked among companies with meaningful Operating margin (%) only.
AVMXY' s Operating margin (%) Range Over the Past 10 Years
Min: -1723.37  Med: -288.30 Max: -178.34
Current: -632.09
-1723.37
-178.34
Net-margin (%) -436.02
AVMXY's Net-margin (%) is ranked lower than
87% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.79 vs. AVMXY: -436.02 )
Ranked among companies with meaningful Net-margin (%) only.
AVMXY' s Net-margin (%) Range Over the Past 10 Years
Min: -1614.68  Med: -242.44 Max: -57.58
Current: -436.02
-1614.68
-57.58
ROE (%) -171.82
AVMXY's ROE (%) is ranked lower than
96% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. AVMXY: -171.82 )
Ranked among companies with meaningful ROE (%) only.
AVMXY' s ROE (%) Range Over the Past 10 Years
Min: -145.87  Med: -86.27 Max: -17.34
Current: -171.82
-145.87
-17.34
ROA (%) -132.49
AVMXY's ROA (%) is ranked lower than
93% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: -0.56 vs. AVMXY: -132.49 )
Ranked among companies with meaningful ROA (%) only.
AVMXY' s ROA (%) Range Over the Past 10 Years
Min: -111.43  Med: -65.83 Max: -13.45
Current: -132.49
-111.43
-13.45
ROC (Joel Greenblatt) (%) -1061.05
AVMXY's ROC (Joel Greenblatt) (%) is ranked lower than
86% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. AVMXY: -1061.05 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AVMXY' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4361.27  Med: -1219.99 Max: -248.87
Current: -1061.05
-4361.27
-248.87
Revenue Growth (3Y)(%) -17.00
AVMXY's Revenue Growth (3Y)(%) is ranked lower than
81% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. AVMXY: -17.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AVMXY' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -33.30 Max: 8.7
Current: -17
0
8.7
EBITDA Growth (3Y)(%) -9.80
AVMXY's EBITDA Growth (3Y)(%) is ranked lower than
69% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. AVMXY: -9.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AVMXY' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -64.1  Med: -14.70 Max: 30.8
Current: -9.8
-64.1
30.8
EPS Growth (3Y)(%) -14.50
AVMXY's EPS Growth (3Y)(%) is ranked lower than
75% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. AVMXY: -14.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
AVMXY' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -57.2  Med: -16.50 Max: 29.4
Current: -14.5
-57.2
29.4
» AVMXY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with AVMXY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 8.75
AVMXY's P/B is ranked lower than
91% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 2.84 vs. AVMXY: 8.75 )
Ranked among companies with meaningful P/B only.
AVMXY' s P/B Range Over the Past 10 Years
Min: 0.28  Med: 2.56 Max: 15
Current: 8.75
0.28
15
P/S 17.50
AVMXY's P/S is ranked lower than
88% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. AVMXY: 17.50 )
Ranked among companies with meaningful P/S only.
AVMXY' s P/S Range Over the Past 10 Years
Min: 1.9  Med: 8.75 Max: 26.85
Current: 17.5
1.9
26.85
Current Ratio 5.62
AVMXY's Current Ratio is ranked higher than
79% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 2.88 vs. AVMXY: 5.62 )
Ranked among companies with meaningful Current Ratio only.
AVMXY' s Current Ratio Range Over the Past 10 Years
Min: 0.02  Med: 5.62 Max: 195.06
Current: 5.62
0.02
195.06
Quick Ratio 5.07
AVMXY's Quick Ratio is ranked higher than
82% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. AVMXY: 5.07 )
Ranked among companies with meaningful Quick Ratio only.
AVMXY' s Quick Ratio Range Over the Past 10 Years
Min: 0.02  Med: 5.07 Max: 195.06
Current: 5.07
0.02
195.06
Days Inventory 476.02
AVMXY's Days Inventory is ranked lower than
93% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 134.42 vs. AVMXY: 476.02 )
Ranked among companies with meaningful Days Inventory only.
AVMXY' s Days Inventory Range Over the Past 10 Years
Min: 101.53  Med: 312.20 Max: 419.94
Current: 476.02
101.53
419.94
Days Sales Outstanding 182.50
AVMXY's Days Sales Outstanding is ranked lower than
89% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 70.19 vs. AVMXY: 182.50 )
Ranked among companies with meaningful Days Sales Outstanding only.
AVMXY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 98.69  Med: 179.48 Max: 346.5
Current: 182.5
98.69
346.5
Days Payable 987.32
AVMXY's Days Payable is ranked higher than
100% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 64.85 vs. AVMXY: 987.32 )
Ranked among companies with meaningful Days Payable only.
AVMXY' s Days Payable Range Over the Past 10 Years
Min: 112.97  Med: 328.22 Max: 524.05
Current: 987.32
112.97
524.05

Valuation & Return

vs
industry
vs
history
Price/Net Cash 14.00
AVMXY's Price/Net Cash is ranked higher than
52% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 14.74 vs. AVMXY: 14.00 )
Ranked among companies with meaningful Price/Net Cash only.
AVMXY' s Price/Net Cash Range Over the Past 10 Years
Min: 0.93  Med: 4.07 Max: 51
Current: 14
0.93
51
Price/Net Current Asset Value 7.00
AVMXY's Price/Net Current Asset Value is ranked lower than
54% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 6.26 vs. AVMXY: 7.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
AVMXY' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.57  Med: 4.33 Max: 34
Current: 7
0.57
34
Price/Tangible Book 8.75
AVMXY's Price/Tangible Book is ranked lower than
80% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 3.66 vs. AVMXY: 8.75 )
Ranked among companies with meaningful Price/Tangible Book only.
AVMXY' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.39  Med: 2.89 Max: 18.35
Current: 8.75
0.39
18.35
Earnings Yield (Greenblatt) (%) -11.10
AVMXY's Earnings Yield (Greenblatt) (%) is ranked lower than
75% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. AVMXY: -11.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AVMXY' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 155.5  Med: 415.20 Max: 83045.2
Current: -11.1
155.5
83045.2

More Statistics

Revenue(Mil) $2
EPS $ -0.31
Beta-0.21
Short Percentage of Float0.00%
52-Week Range $0.93 - 2.46
Shares Outstanding(Mil)28.64

Business Description

Industry: Medical Devices » Medical Devices
Compare:LSE:KMK, OTCBB:NEMDE, MIL:TBS, TSE:7963, SGX:5I0, ROCO:4116 » details
Traded in other countries:AVH.Australia, GCR.Germany,
Avita Medical Ltd. manufactures & sells regenerative & respiratory medical devices. It offers tissue-engineered products for wound & skin defects, spacers for adolescent & adults, ReCell Spray-On-Skin, Funhaler for asthma & Breath-ATech, among others.
» More Articles for AVMXY

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Regenerative Medicine Approach Delivers Healing and Cost Savings for Chronic Wounds May 01 2016
Avita Medical Announces Financial Results for Third Quarter Fiscal 2016 Apr 29 2016
Avita Medical -- Shareholder Letter Apr 29 2016
International Experts Honoured With Awards at 4th Annual Skin Regeneration Symposium Apr 22 2016
International Experts to Present on Avita Medical's Regenerative Medicine Approach at Medical... Apr 22 2016
ReGenerCell(TM) Skin Regeneration Technology Decreases Size and Pain in Chronic Wounds Apr 19 2016
Skin Regeneration Technology Critical to Recovery and Quality of Life in Burns Patients Say Top... Apr 18 2016
Avita Medical Announces 4th Annual Skin Regeneration Symposium Apr 05 2016
Avita Medical Completes Repigmentation Study Enrollment Mar 14 2016
Avita secures major China deal Mar 11 2016
Avita Medical Signs Distributor Deal With China's Largest Healthcare Group Mar 10 2016
Positive results on leg ulcer trial: Avita Mar 09 2016
Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell(TM)... Mar 08 2016
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient... Mar 07 2016
Avita Medical Launches Expanded Regenerative Product Range in Europe Mar 02 2016
Avita Medical Announces Financial Results for First Half Fiscal 2016 Feb 26 2016
Avita Medical Appoints Distributor for Germany, Switzerland, Austria Feb 11 2016
Avita Medical Completes Sale of Respiratory Business for $2.47m Feb 05 2016
Avita Medical Announces Financial Results for Second Quarter Fiscal 2016 Jan 28 2016
Avita Medical CEO Long Term Incentive Plan Jan 25 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK